Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Izervay
Izervay
Astellas takes $760M charge, reveals slowdown for eye drug Izervay after regulatory stumbles
Fierce Pharma
Wed, 02/5/25 - 10:54 pm
Astellas
Europe
Izervay
Astellas CRL ‘clearly a positive’ for Apellis, says JPMorgan
Tip Ranks
Tue, 11/19/24 - 11:13 am
Astellas
Apellis
FDA
geographic atrophy
Izervay
Syfovre
Astellas doesn't see eye to eye with Europe on geographic atrophy drug Izervay
Fierce Pharma
Mon, 10/28/24 - 06:12 pm
Astellas
Izervay
Apellis
Syfovre
geographic atrophy
Europe
Astellas’ Izervay reduces GA lesion growth in Phase III trial
Clinical Trials Arena
Mon, 11/6/23 - 09:51 am
Astellas
Izervay
geographic atrophy
age-related macular degeneration
clinical trials
Iveric Bio Announces Positive 24-Month Topline Results from Phase 3 Study of Izervay for Geographic Atrophy
PR Newswire
Tue, 09/19/23 - 10:28 am
Astellas
clinical trials
Izervay
geographic atrophy
Iveric drug approved for type of vision loss as rival’s safety draws scrutiny
BioPharma Dive
Sun, 08/6/23 - 09:25 pm
Iveric Bio
geographic atrophy
FDA
Izervay
Astellas